TickerKhojHospitals & Diagnostics · Hospital/Nursing Management · NSE: RAINBOW · data 2026-11-03
Rainbow Childrens Medicare Limited
In plain words
Price: 23.0% below its 52-week high of ₹1,610.
Delivery: 54.0% of traded shares were kept for delivery over the last 10 sessions, against 55.5% over the last 60.
Latest results: a net profit of ₹82 cr for the quarter ended Sept 2026 (+9.1% on the same quarter a year earlier).
A description of the data, not a recommendation.
Key figures
Growth
| Revenue (last 12 months) | ₹1,820 cr |
| Net profit (last 12 months) | ₹285 cr |
| Sales growth, 3 years (yearly) | 13.2% |
| Profit growth, 3 years (yearly) | 9.7% |
At a glance
Promoters 49.8% (unchanged in a year), pledged 0.0%, institutions 37.9%.
P/E 44.1, dividend yield 0.3%. Price relative to earnings and book value (low is cheaper, not better).
ROE 17.9%, ROCE 16.5%, operating margin 22.9%: how much profit it earns on the money it uses.
Debt/equity 0.54, Profit growth 9.7% and sales growth 13.2% a year over 3 years.
Ratings use fixed thresholds on the latest reported figures. They describe the numbers and are not a recommendation.
Strengths and limitations
- Healthy operating margin (22.9%).
None flagged by these rules.
Picked automatically from the latest reported figures with fixed rules; check the company's filings before relying on them.
Latest results in brief (Q2 FY27)
RAINBOW Q2 FY27 results (consolidated figures, as filed on NSE).
Revenue was ₹548.02 crore, up 23.2% YoY and up 16.6% QoQ.
Net profit was ₹82.09 crore, up 9.1% YoY and up 35.5% QoQ.
Operating margin was 31% (33.5% a year ago).
EPS was ₹8.1, up 9.3% YoY and up 35.7% QoQ.
RAINBOW के Q2 FY27 नतीजे (कंसोलिडेटेड आंकड़े, NSE पर दाखिल)।
राजस्व: ₹548.02 करोड़; पिछले साल की तुलना में 23.2% की बढ़त, पिछली तिमाही की तुलना में 16.6% की बढ़त।
शुद्ध मुनाफ़ा: ₹82.09 करोड़; पिछले साल की तुलना में 9.1% की बढ़त, पिछली तिमाही की तुलना में 35.5% की बढ़त।
ऑपरेटिंग मार्जिन: 31% (एक साल पहले 33.5%)।
EPS: ₹8.1; पिछले साल की तुलना में 9.3% की बढ़त, पिछली तिमाही की तुलना में 35.7% की बढ़त।
RAINBOWના Q2 FY27 પરિણામો (કન્સોલિડેટેડ આંકડા, NSE પર ફાઇલ કરેલા).
આવક (રેવન્યુ): ₹548.02 કરોડ; ગયા વર્ષની સરખામણીએ 23.2% વધારો, ગયા ક્વાર્ટરની સરખામણીએ 16.6% વધારો.
ચોખ્ખો નફો: ₹82.09 કરોડ; ગયા વર્ષની સરખામણીએ 9.1% વધારો, ગયા ક્વાર્ટરની સરખામણીએ 35.5% વધારો.
ઓપરેટિંગ માર્જિન: 31% (એક વર્ષ પહેલાં 33.5%).
EPS: ₹8.1; ગયા વર્ષની સરખામણીએ 9.3% વધારો, ગયા ક્વાર્ટરની સરખામણીએ 35.7% વધારો.
Written from the filed numbers. Not a recommendation.
Smart-money activity
16/100 · Weak over the last ~60 sessions, data 2026-11-02
- Delivery vs usual 3/30: Delivery 53.3% over the last 20 sessions vs 57.2% in the 40 before (0.93x); shares delivered per day 1.19x usual; 0 delivery-spike days (3x usual shares delivered, 40%+ delivery) in the last 20 sessions.
- Bulk/block deals 0/20: No bulk or block deals in the last 90 days.
- Insider / SAST buys 0/15: No insider buy or SAST acquisition filings in the last 90 days. Insider sells are not collected by the site, so only buy filings count.
- Mutual fund holding 7/15: 6 schemes hold it, about ₹135 cr in all (as of 2026-09-30). Latest monthly portfolios only (top 60 holdings per scheme); month-on-month change is not stored.
- Accumulation evidence 1/15: Verdict "None", sustained score 39/100.
- Promoter pledges 5/5: No promoter pledge filings in 90 days.
A description of recorded activity (delivery, deals, insider buys, fund holding, pledges), not a recommendation. Today's most active stocks.
Story so far
● Results ● Dividend
- 31 Oct 26Results Q2 FY27 results: profit +9.1% YoY +1.7% next session
- 9 Oct 26Results Q4 FY26 results: profit +36.7% YoY -0.1% next session
- 30 Jul 26Results Q1 FY27 results: profit +13.2% YoY +1.9% next session
- 21 Jul 26Dividend Dividend ₹3.5 (ex-date) -0.2% next session
- 28 Jan 26Results Q3 FY26 results: profit +5.6% YoY -0.3% next session
- 13 Nov 25Results Q2 FY26 results: profit −4.6% YoY -1.3% next session
- 26 Jul 25Results Q1 FY26 results: profit +35.3% YoY -1.0% next session
- 27 Jun 25Dividend Dividend ₹3 (ex-date) +3.5% next session
- 24 May 25Results Q4 FY25 results: profit +10.5% YoY +0.4% next session
- 10 Feb 25Results Q3 FY25 results: profit +10.6% YoY -5.3% next session
From official exchange filings and NSE data. How the price moved after an event describes the past, not what comes next.
Quarterly results (consolidated)
| Quarter | Revenue | Net profit | Profit YoY | Op. margin | EPS ₹ |
|---|---|---|---|---|---|
| Sept 2026 | ₹548 cr | ₹82 cr | +9.1% | 31.0% | 8.1 |
| Jun 2026 | ₹470 cr | ₹61 cr | +13.2% | 28.6% | 5.97 |
| Mar 2026 | ₹460 cr | ₹77 cr | +36.7% | 31.5% | 7.59 |
| Dec 2025 | ₹445 cr | ₹73 cr | +5.6% | 33.0% | 7.14 |
Shareholding trend
| Holder | Sept 2026 | Jun 2026 | Mar 2026 | Dec 2025 |
|---|---|---|---|---|
| Promoters | 49.83% | 49.84% | 49.84% | 49.84% |
| Foreign institutions (FII) | 14.66% | 16.03% | 17.24% | 19.23% |
| Domestic institutions (DII) | 23.28% | 22.56% | 21.13% | 19.49% |
| Mutual funds | 18.84% | 18.53% | 17.46% | 15.49% |
| Retail investors | 5.53% | 5.13% | 5.42% | 5.32% |
| Number of shareholders | 92,814 | 89,305 | 88,561 | 88,809 |
Common questions
What was Rainbow Childrens Medicare Limited's latest quarterly profit?
Rainbow Childrens Medicare Limited reported a net profit of ₹82 cr for the quarter ended Sept 2026 (+9.1% on the same quarter a year earlier), on revenue of ₹548 cr.
How much do promoters hold in Rainbow Childrens Medicare Limited?
Promoters held 49.83% of Rainbow Childrens Medicare Limited at the end of Sept 2026, with 0.00% of promoter shares pledged.
Is Rainbow Childrens Medicare Limited debt-free?
Its latest reported debt-to-equity ratio is 0.54.
What is Rainbow Childrens Medicare Limited's P/E ratio?
About 44.1, based on the last 12 months' earnings and a price of ₹1,239.2 (data 2026-11-03).
What is the 52-week high and low of Rainbow Childrens Medicare Limited?
The 52-week high is ₹1,610 and the 52-week low is ₹1,084.
Mutual funds holding Rainbow Childrens Medicare Limited
From the monthly portfolios of the fund houses the site reads, as of 2026-09-30. 6 schemes holding about ₹135 cr; funds that hold it outside their top holdings may not be listed.
| Scheme | Fund house | % of fund | Value |
|---|---|---|---|
| SBI Healthcare Opportunities Fund | SBI Mutual Fund | 0.67% | ₹39 cr |
| Nippon India Innovation Fund | Nippon India Mutual Fund | 1.00% | ₹29 cr |
| Nippon India Aggressive Hybrid Fund | Nippon India Mutual Fund | 0.72% | ₹28 cr |
| Nippon India Consumption Fund | Nippon India Mutual Fund | 0.88% | ₹20 cr |
| An open ended fund for investment for children having a lock-in for at least 5 years or till the child attains age of majority | Aditya Birla Sun Life Mutual Fund | 1.59% | ₹19 cr |
| Mirae Asset Nifty 500 Healthcare ETF | Mirae Asset Mutual Fund | 0.49% | ₹0 cr |
Compared with similar companies
| Company | Price | Market cap | P/E | P/B | ROE | ROCE | Debt/eq. | 1-yr return |
|---|---|---|---|---|---|---|---|---|
| Rainbow Childrens Medicare Limited | ₹1,239.2 | ₹12,366 cr | 44.1 | — | 17.9% | 16.5% | 0.54 | -11.1% |
| Park Medi World Limited | ₹223.87 | ₹9,513 cr | — | — | 16.7% | 20.2% | 0.18 | +41.0% |
| Yatharth Hospital and Trauma Care Services Limited | ₹938.4 | ₹8,942 cr | 49.9 | — | 10.4% | 11.6% | 0.15 | +19.3% |
| HealthCare Global Enterprises Ltd. | ₹586.8 | ₹8,731 cr | 376 | — | 1.2% | 8.3% | 1.3 | -22.3% |
| Jupiter Life Line Hospitals Ltd. | ₹263.6 | ₹8,402 cr | 46.3 | 5.3 | 13.4% | 13.2% | 0.38 | -18.0% |
| Paras Healthcare Limited | ₹739.3 | ₹7,963 cr | — | 18.9 | 13% | 13.8% | 3.53 | +2.7% |
Compare RAINBOW with PARKHOSPS in detail →
The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.
Open RAINBOW in TickerKhoj →